Early research (Phase 1)Study completedNCT01482611
What this trial is testing
A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382
Who this might be right for
Hepatitis C Virus Infection
Janssen R&D Ireland 35